Compare OESX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OESX | CCEL |
|---|---|---|
| Founded | 1996 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 32.7M |
| IPO Year | 2007 | 2022 |
| Metric | OESX | CCEL |
|---|---|---|
| Price | $9.88 | $3.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | ★ 32.9K | 7.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $79,720,000.00 | $25,384,279.00 |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $13.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $0.55 | $3.10 |
| 52 Week High | $18.64 | $6.99 |
| Indicator | OESX | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 29.94 | 29.97 |
| Support Level | $8.03 | $3.11 |
| Resistance Level | $10.17 | $3.57 |
| Average True Range (ATR) | 0.75 | 0.04 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 12.03 | 0.00 |
Orion Energy Systems Inc is engaged in light-emitting diode lighting systems, wireless Internet of Things-enabled control solutions, project engineering, energy project management design, maintenance services, and turnkey electric vehicle charging stations and related installation services to commercial and industrial businesses, and federal and local governments, predominantly in North America. The group has three segments: the Orion lighting segment, the Orion maintenance segment, and the Orion electric vehicle charging segment. It generates the majority of its revenue from the Orion lighting segment, which develops and sells lighting products and provides construction and engineering services for Orion's commercial lighting and energy management systems.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.